The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder
- PMID: 18255269
- DOI: 10.1016/j.schres.2007.12.470
The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder
Abstract
Among outpatients with schizophrenia, antipsychotic non-adherence is common, grossly under-detected by patients and their prescribers, and is associated with poor clinical outcomes. Using electronic monitoring (EM) as the reference standard we evaluated the reliability and validity as well as the sensitivity and specificity of a recently developed, brief, pencil-paper, clinician-administered adherence instrument [the Brief Adherence Rating Scale (BARS)] to assess the oral antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. EM and BARS adherence and symptom severity ratings were gathered at baseline and prospectively at 6 monthly visits in 61 participants (n=35 with schizophrenia; n=26 with schizoaffective disorder). A significant positive relationship was found between mean BARS and EM adherence (beta=0.98; rs=0.59, p<0.0001). Cronbach's coefficient alpha revealed very high internal reliability for the BARS (alpha=0.92). A moderate-to-strong degree of test-retest reliability was also found for the BARS (beta ranged from 0.53 to 0.92 and rs ranged from 0.46 to 0.86). Regarding concurrent validity of the BARS, greater mean BARS adherence was significantly related to lower mean PANSS total scores (beta=-0.40; rs=-0.39, p=0.002) and to lower mean Positive symptom sub-scale scores (beta=-0.08, p=.007; rs=-0.28, p=.02). An initial 3-month monitoring period with the BARS also demonstrated good sensitivity (73%) and specificity (74%) in identifying non-adherent outpatients (defined as <70% mean EM adherence). Relative to EM, the BARS appears to provide valid, reliable, sensitive, and specific estimates of antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. The BARS appears to be a promising candidate as a brief adherence assessment instrument for feasible use in community-based settings.
Similar articles
-
Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity.Psychiatry Res. 2008 Jan 15;157(1-3):259-63. doi: 10.1016/j.psychres.2007.05.001. Epub 2007 Nov 1. Psychiatry Res. 2008. PMID: 17935793
-
Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: a comparison of first- vs. second-generation antipsychotics.Schizophr Res. 2006 Feb 15;82(1):107-14. doi: 10.1016/j.schres.2005.10.015. Epub 2005 Dec 22. Schizophr Res. 2006. PMID: 16376522 Clinical Trial.
-
A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia.Psychiatry Res. 2005 Feb 28;133(2-3):129-33. doi: 10.1016/j.psychres.2004.11.002. Psychiatry Res. 2005. PMID: 15740989
-
Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.Arch Gen Psychiatry. 2005 Sep;62(9):961-70. doi: 10.1001/archpsyc.62.9.961. Arch Gen Psychiatry. 2005. PMID: 16143728 Review.
-
Strategies for improving treatment adherence in schizophrenia and schizoaffective disorder.J Clin Psychiatry. 2010;71 Suppl 2:20-6. doi: 10.4088/JCP.9096su1cc.04. J Clin Psychiatry. 2010. PMID: 21190649 Review.
Cited by
-
Examination of heterogeneity in treatment response to antipsychotic medications.Schizophr Res. 2019 Sep;211:100-102. doi: 10.1016/j.schres.2019.07.033. Epub 2019 Aug 1. Schizophr Res. 2019. PMID: 31378553 Free PMC article. Clinical Trial. No abstract available.
-
Interepisodic Functioning in Patients with Bipolar Disorder in Remission.Indian J Psychol Med. 2018 Jan-Feb;40(1):52-60. doi: 10.4103/IJPSYM.IJPSYM_211_17. Indian J Psychol Med. 2018. PMID: 29403131 Free PMC article.
-
The enduring challenge of antipsychotic non-adherence.World Psychiatry. 2013 Oct;12(3):236-7. doi: 10.1002/wps.20079. World Psychiatry. 2013. PMID: 24096787 Free PMC article. No abstract available.
-
Predictors of medication adherence in a large 1-year prospective cohort of individuals with schizophrenia: insights from the multicentric FACE-SZ dataset.Transl Psychiatry. 2023 Nov 7;13(1):341. doi: 10.1038/s41398-023-02640-x. Transl Psychiatry. 2023. PMID: 37935695 Free PMC article.
-
Does religiosity in persons with schizophrenia influence medication adherence.Indian J Psychiatry. 2021 May-Jun;63(3):228-232. doi: 10.4103/psychiatry.IndianJPsychiatry_413_20. Epub 2021 Jun 17. Indian J Psychiatry. 2021. PMID: 34211214 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical